Clariant AG

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: CH0012142631
CHF
7.28
-0.09 (-1.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Clariant AG stock-summary
stock-summary
Clariant AG
Specialty Chemicals
Clariant AG is a Switzerland-based producer of specialty chemicals. It operates through four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics and Coatings. The Care Chemicals business area produces ingredients for laundry detergents, fabric softeners, disinfectants and dishwashing detergents, as well as plasticizers, de-icing fluids for aircrafts and runways, and special solvents. The Catalysis business area offers a wide range of catalysts for the petrochemicals, plastics and refining industries. The Natural Resources business area provides products and services to the minerals and oil and mining industries. The Plastics and Coatings business area produces color and additive concentrates and performance solutions for plastics, flame retardants, polymer additives and waxes for functional effects in plastics, coatings, inks and other special applications, as well as organic pigments, pigment preparations and specialty dyes.
Company Coordinates stock-summary
Company Details
Rothausstrasse 61 , MUTTENZ None : 4132
stock-summary
Tel: 41 61 469511141 61 4696373
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Hariolf Kottmann
Executive Chairman of the Board, Interim Chief Executive Officer
Dr. Khaled Nahas
Non-Executive Independent Vice Chairman of the Board
Dr. Eveline Saupper
Lead Non-Executive Independent Director
Mr. Abdullah Alissa
Non-Executive Independent Director
Mr. Calum MacLean
Non-Executive Independent Director
Mr. Geoffery Merszei
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,526 Million
(Quarterly Results - Dec 2015)
Net Profit:
24 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

CHF 2,412 Million ()

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.28%

stock-summary
Debt Equity

0.76

stock-summary
Return on Equity

17.22%

stock-summary
Price to Book

1.26